Your browser doesn't support javascript.
loading
Generalizability of machine learning in predicting antimicrobial resistance in E. coli: a multi-country case study in Africa.
Nsubuga, Mike; Galiwango, Ronald; Jjingo, Daudi; Mboowa, Gerald.
Afiliação
  • Nsubuga M; Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, P.O Box 7072, Kampala, Uganda.
  • Galiwango R; The African Center of Excellence in Bioinformatics and Data-Intensive Sciences, Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O Box 22418, Kampala, Uganda.
  • Jjingo D; Faculty of Health Sciences, University of Bristol, Bristol, BS40 5DU, UK.
  • Mboowa G; Jean Golding Institute, University of Bristol, Bristol, BS8 1UH, UK.
BMC Genomics ; 25(1): 287, 2024 Mar 18.
Article em En | MEDLINE | ID: mdl-38500034
ABSTRACT

BACKGROUND:

Antimicrobial resistance (AMR) remains a significant global health threat particularly impacting low- and middle-income countries (LMICs). These regions often grapple with limited healthcare resources and access to advanced diagnostic tools. Consequently, there is a pressing need for innovative approaches that can enhance AMR surveillance and management. Machine learning (ML) though underutilized in these settings, presents a promising avenue. This study leverages ML models trained on whole-genome sequencing data from England, where such data is more readily available, to predict AMR in E. coli, targeting key antibiotics such as ciprofloxacin, ampicillin, and cefotaxime. A crucial part of our work involved the validation of these models using an independent dataset from Africa, specifically from Uganda, Nigeria, and Tanzania, to ascertain their applicability and effectiveness in LMICs.

RESULTS:

Model performance varied across antibiotics. The Support Vector Machine excelled in predicting ciprofloxacin resistance (87% accuracy, F1 Score 0.57), Light Gradient Boosting Machine for cefotaxime (92% accuracy, F1 Score 0.42), and Gradient Boosting for ampicillin (58% accuracy, F1 Score 0.66). In validation with data from Africa, Logistic Regression showed high accuracy for ampicillin (94%, F1 Score 0.97), while Random Forest and Light Gradient Boosting Machine were effective for ciprofloxacin (50% accuracy, F1 Score 0.56) and cefotaxime (45% accuracy, F1 Score0.54), respectively. Key mutations associated with AMR were identified for these antibiotics.

CONCLUSION:

As the threat of AMR continues to rise, the successful application of these models, particularly on genomic datasets from LMICs, signals a promising avenue for improving AMR prediction to support large AMR surveillance programs. This work thus not only expands our current understanding of the genetic underpinnings of AMR but also provides a robust methodological framework that can guide future research and applications in the fight against AMR.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escherichia coli / Antibacterianos País como assunto: Africa Idioma: En Ano de publicação: 2024 Tipo de documento: Article